Kelmara Health claims the missing middle of psychedelic care

Field notes

Kelmara frames psychedelic treatment as an operations problem spanning payer approval, REMS enrollment, an eight-hour monitored session, documentation, and post-session claims. Its proposed agents assemble authorization packets, track appeals, verify enrollment, and coordinate administrative work while clinicians handle clinical decisions. The page says the system runs in the customer's own cloud and sits on top of Epic, Osmind, or another existing EHR. It reports current use with Spravato programs and presents psilocybin support as a stated future readiness target.